Back to Search Start Over

170P Advanced non-small cell lung cancer patients with low tumor mutation burden might derive benefit from anti-programmed cell death (PD)-1 and anti-programmed deathligand 1 (PD-L1) blockade.

Authors :
Nie, W
Xu, M-D
Gan, L
Zhang, Y
Han, B-H
Source :
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Publication Year :
2019

Subjects

Subjects :
*NON-small-cell lung carcinoma
*CELL death
*CANCER patients

Details

Language :
English
ISSN :
09237534
Volume :
30
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
136076542
Full Text :
https://doi.org/10.1093/annonc/mdz063.068
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details